Clinical Trials Browser

Recruiting × Interventional × Alzheimer Disease × Clear all

NCT06745583 2026-06-03

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Phase 2 Recruiting

15 enrolled

Lymphoid

Neuroinflammatory Diseases, Alzheimer Disease, Lymphoma, Follicular, Neurodegenerative Diseases, Cognitive Dysfunction

NCT07102212 2026-05-18

FOCUS

Phase NA Recruiting

120 enrolled

BreastDermatologicGenitourinaryPlasma cellThoracic

Alzheimer Disease, Anxiety Disorders, Breast Neoplasms, Depression, Fatigue, Lung Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

NCT07532590 2026-05-11

Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).

Phase NA Recruiting

185 enrolled

Agnosia, Alzheimer Disease

NCT06362707 2026-05-04

FEAD

Phase 2 Recruiting

200 enrolled

Lymphoid

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

NCT07332377 2026-03-18

PsyMINT

Phase NA Recruiting

25 enrolled

Agnosia, Alzheimer Disease, Pain

NCT06377033 2025-07-20

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Phase NA Recruiting

1,000 enrolled

CNSEndocrine

Alzheimer Disease, Paraganglioma, Parkinson Disease, Pheochromocytoma, Polyneuropathies, Aortic Aneurysm, Thoracic, Genetic Predisposition to Disease, Frontotemporal Dementia

NCT07006155 2025-06-05

Biograph Vision 600 Versus Biograph Vision.X PET/CT

Phase NA Recruiting

40 enrolled

Alzheimer Disease, Neoplasms

NCT06444841 2024-07-09

Paper-Based and Smartphone-Based Memory Supports

Phase NA Recruiting

200 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction